Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Cell 149, 274293, 10.1016/j.cell.2012.03.017 (2012)
Specific Clinical Relevance Osteoarthritis GLP-1's primary advantage in OA is its dual capacity to modulate synovial macrophage polarization (M1M2) while directly inhibiting cartilage matrix-degrading enzymes (MMP-3, MMP-13, ADAMTS-4/5) and promoting COL2 and aggrecan synthesis
Sikiri P, Seiwerth S, et al
Stringent Regulatory Barriers: The launch of copper peptide-based products is hamper by regulatory clearances in certain countries
US$ 23.51
US$ 28.85
US$ 19.99
US$ 29.21
US$ 21.93
US$ 21.72
US$ 23.46
